Back
Speaker illustration

Doctor Riccardo Perfetti

New York (United States of America)

Presentations

Diabetic Cardiomyopathy: baseline Characteristics of patients enrolled into the ARISE-HF trial

Event: Heart Failure 2023

Topic: Comorbidities

Session: ePosters in chronic heart failure - comorbidities 3

Access
Like
Thumbnail

Beneficial effects of AT-001, an aldose reductase inhibitor, in rodent models of diabetic cardiomyopathy

Event: Heart Failure 2019

Topic: Comorbidities

Session: Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

Access
Like
Thumbnail

Safety and proof of biological activity support clinical development of AT-001 for diabetic cardiomyopathy: a phase 1/2 study

Event: Heart Failure 2019

Topic: Comorbidities

Session: Clinical Forum - Sat.25 May 08:30 - Tues. 28 May at 12:30

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources